Overview Financials News + Filings Key Docs Charts Ownership Insiders
|
|
Teligent, Inc. (TLGT)
|
|
| Segments |
|
|
|
|
Annual | Quarterly | TTM |
|
| In millions, except per share items | Jun-30-21 | Mar-31-21 | Sep-30-20 | Jun-30-20 | Jun-05-20 | Mar-31-20 | Mar-05-20 | Dec-31-19 |
| | 10-Q | 10-Q | 10-Q | 10-Q | 8-K | 10-Q | 8-K | 10-K |
| Revenues |
| Company product sales | 26.1 | 32.8 | 13.9 | 36.7 | | 23.2 | | 15.7 |
| Topical | 5.5 | 7.0 | 12.0 | 8.8 | | 5.4 | | 10.9 |
| Injectables | 4.2 | 3.6 | 2.0 | 4.2 | | 1.8 | | 4.8 |
| Contract manufacturing sales | 0.7 | 0.8 | 0.3 | 0.3 | | 0.2 | | 0.3 |
| Research and development services and other income | 0.0 | 0.2 | 0.1 | 0.3 | | 0.1 | | 0.0 |
| |
| Mix |
| Company product sales | 249.8% | 283.5% | 97.2% | 270.3% | | 311.1% | | 98.3% |
| Topical | 52.5% | 60.6% | 83.6% | 64.6% | | 72.2% | | 68.3% |
| Injectables | 40.7% | 30.9% | 13.6% | 31.3% | | 23.6% | | 30.0% |
| Contract manufacturing sales | 6.8% | 7.1% | 2.1% | 2.3% | | 2.6% | | 1.7% |
| Research and development services and other income | 0.0% | 1.5% | 0.7% | 1.8% | | 1.5% | | 0.0% |
| |
| Growth |
| Company product sales | -29.0% | 41.8% | -23.6% | 105.5% | | 85.4% | | 2.6% |
| Topical | -37.6% | 30.5% | -9.7% | -32.2% | | -40.4% | | 23.7% |
| Injectables | -0.2% | 103.2% | -60.6% | -13.8% | | -49.2% | | -26.1% |
| Contract manufacturing sales | 130.0% | 315.2% | 83.2% | -20.1% | | -63.7% | | -81.4% |
| Research and development services and other income | -98.4% | 57.7% | 40.8% | 195.3% | | 30.6% | | -96.2% |
|